Our Portfolio Companies

Companies built from the ground up based on high impact technologies exclusively licensed from top research institutions around the world.

Now Funding
Solenic Medical, Inc. is a medical device company developing an innovative non-invasive treatment for infected metallic implants in the body, reducing the need for additional surgeries.
Funded
Akeso Biomedical is an animal performance and food safety company developing new solutions to improve gut health and treat bacterial infections using a broad-spectrum chemistry.
Funded
ACQUIRED | Ascendant Dx is a bioscience company whose mission is to commercialize disruptive diagnostic technologies aiding identification and treatment for diseases of women and children.
Funded
BiologicsMD is developing highly targeted, novel human therapeutics for hair loss diseases and conditions, as well as severe bone disorders.
Funded
ACQUIRED | BlueInGreen (BIG) designs, manufactures and services the most efficient gas dissolution equipment for water and wastewater treatment.
Funded
Calyxo is developing a disruptive solution for kidney stone removal that is faster, easier, and better for patients, clinicians and hospitals.
Funded
CardioWise offers a new approach to cardiac diagnostics – applying machine learning technology to image processing to create transparent, unbiased, clinical evaluation.
Funded
OsteoVantage™ is developing bioelectric stimulation technology that is targeted at transforming spine and orthopedics treatments with its proprietary INDOS™ (Induced Osteogenic Stimulation) technology
Funded
Vixiar Medical develops non-invasive devices and systems for monitoring cardiopulmonary diseases, particularly those with significant clinical and economic burden.
Funded
Zebra Analytix is focused on creating game-changing analytical solutions spanning diverse, high-impact applications where rapid detection is essential